Latest Payments News

Vault Minerals reports a robust FY25 with soaring gold production and profits, underpinned by operational upgrades and a strategic share buy-back.

Hastings Technology Metals has completed its acquisition of Great Western Gold, gaining a major stake in the Whiteheads Gold Project near Kalgoorlie. The company aims to define a maiden JORC resource by Q4 2025, leveraging extensive historical data and near-term drilling plans.

VEEM Ltd posted a 15% revenue decline and a 57% net profit drop for FY25, reflecting cyclical defence contract impacts. The company secured a $65 million ASC contract extension and continues investing in R&D and automation to drive future growth.

Genesis Minerals Limited reported a remarkable 110% surge in revenue for FY2025 alongside a strategic acquisition of the Laverton Gold Project, signaling a bold growth phase.

Northern Star Resources has announced a fully franked dividend of AUD 0.30 per share for the first half of 2025, offering shareholders a Dividend Reinvestment Plan with no discount.

Finbar Group Limited reported a robust FY25 with a 16% rise in underlying profit and a strong $1 billion development pipeline, signalling confidence in Western Australia's property market.

Super Retail Group has announced it will suspend its Dividend Reinvestment Plan starting fiscal year 2026, shifting shareholders to cash dividends instead. The DRP remains active for FY25 final and special dividends.

Super Retail Group Limited has announced a fully franked dividend of AUD 0.64 per share, combining ordinary and special dividends, payable in October 2025 with a Dividend Reinvestment Plan available.

Heartland Group Holdings Limited has announced an ordinary dividend of NZD 0.02352941 per share for the half-year ending June 2025, payable in September with a dividend reinvestment plan available.

Auckland International Airport has announced a NZD 0.082 dividend for the first half of fiscal 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount to shareholders.

Euroz Hartleys Group Limited reported a robust 87.7% increase in net profit for FY25, driven by growth across brokerage, underwriting, and wealth management. The company declared a fully franked full-year dividend of 5.5 cents per share, reflecting confidence in its operational leverage and balance sheet strength.

Prescient Therapeutics reported an 11.1% reduction in net loss for FY2025, progressing its lead candidate PTX-100 into Phase 2a trials with FDA Fast Track and Orphan Drug designations, supported by a recent $9.8 million capital raise.